Banning energy drinks sales to children

The Government is seeking the public’s views on banning sales of energy drinks to children and young people. The plan is part of its strategy to halve childhood obesity by 2030.
More than two-thirds of 10- to 17-year-olds and a quarter of 6- to 9-year-olds consume …

More details...

Lorcaserin hits the headlines

Public faith that a solution to obesity can be found in medication received a boost with the enthusiastic response of lay media to the results of the CAMELLIA–TIMI 61 (Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients–Thrombolysis in Myocardial Infarction 61) trial …

More details...

Large UK trials test aspirin and omega-3 fatty acids

The UK ASCEND Study Group recently reported large trials that addressed two thorny issues in its study population of 15,480 people with diabetes but no cardiovascular disease.
The balance of risk and benefit with aspirin in people with diabetes has lately been against primary prevention. This …

More details...

Diabetes toolkit for university students

Diabetes UK, the Juvenile Diabetes Research Foundation and NHS England have developed a toolkit for young people with type 1 diabetes who are attending university or college (http://uni.jdrf.org.uk). The toolkit includes advice on lifestyle, independent living and making the most of the resources available to …

More details...

Not all type 2 diabetes reversible by extreme weight loss

Pancreatic cells in people with type 2 diabetes may not recover the ability to produce sufficient insulin if they do not overcome ‘the stress of being surrounded by internal fat’, according to Professor Roy Taylor, joint lead investigator of the DiRECT trial.
 DiRECT showed that extreme …

More details...

Negative results clear empagliflozin and liraglutide, no cancer benefit with aspirin

Three analyses of large studies involving people with diabetes have all proved negative – with different implications.
Boerhinger Ingelheim has reported an analysis of pooled data from trials of its SGLT2 inhibitor empagliflozin involving over 12,000 patients to determine its impact on the risk of bone …

More details...

2nd generation antipsychotics reduce insulin sensitivity and cause weight gain in young people

Second generation antipsychotics are associated with clinically evident metabolic effects in young people after only 12 weeks, say US researchers (JAMA Psychiatry June 13, 2018. doi:10.1001/jamapsychiatry.2018.1088).
The study involved 144 young people aged 6 – 18 (mean 11) who were considered for treatment with an antipsychotic …

More details...

Diabetes and pancreatic cancer

‘Recent-onset diabetes is a manifestation of pancreatic cancer and long-standing diabetes is a risk factor for this malignancy’, say US investigators (Journal of the National Cancer Institute, djy090, https://doi.org/10.1093/jnci/djy090).
Their cohort study included 49,000 people of African American or Latin ethnic origin who did not have …

More details...

Too much and too little sleep linked with metabolic syndrome

The Health Examinees (HEXA) Study is a cohort study in South Korea designed to investigate the epidemiological, genetic and environmental factors that are associated with major chronic diseases in the population (Asian Pac J Cancer Prev 2015;16:1591-7).
A recent analysis of 133,600 participants enrolled between 2004 …

More details...

UK children consume a year’s worth of sugar in 6 months

This eye-catching headline comes from Public Health England’s (PHE) publicity for its Change4Life campaign (www.nhs.uk/change4life). PHE says UK children aged 4 – 10 consume sugar equivalent to an average of 13 cubes per day compared with a recommended limit of 5 – 6. Intake is …

More details...

Web design and marketing agency Leamington Spa